160 related articles for article (PubMed ID: 65208)
21. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
22. The management of generalised grade 2 non-Hodgkin's lymphomas (Report no 18).
Pettingale KW
Clin Radiol; 1981 Sep; 32(5):553-6. PubMed ID: 7273650
[TBL] [Abstract][Full Text] [Related]
23. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
Lombardo M; Morabito F; Merli F; Molica S; Cavanna L; Sacchi S; Broglia C; Angrilli F; Ilariucci F; Stelitano C; Luisi D; Bertè R; Luminari S; Federico M; Brugiatelli M;
Leuk Lymphoma; 2002 Sep; 43(9):1795-801. PubMed ID: 12685834
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy of the non-Hodgkin's lymphomas.
Pasmantier MW; Coleman M; Silver RT
Med Clin North Am; 1976 Sep; 60(5):1043-52. PubMed ID: 59842
[No Abstract] [Full Text] [Related]
25. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
26. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
27. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
28. Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
Pichler E; Jürgenssen OA; Radaszkiewicz T; Reinartz G; Mutz I; Urban C; Krepler P; Schmidmeier W; Becker H; Kundi M
Cancer; 1982 Dec; 50(12):2740-6. PubMed ID: 6897203
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
[No Abstract] [Full Text] [Related]
30. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
Case DC
Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
[TBL] [Abstract][Full Text] [Related]
33. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
34. Recent trends in the treatment of non-Hodgkin's lymphomas.
Bonadonna G; Lattuada A; Banfi A
Eur J Cancer (1965); 1976 Sep; 12(9):661-73. PubMed ID: 971688
[No Abstract] [Full Text] [Related]
35. Combined modality treatment in stage I and II diffuse non-Hodgkin's lymphomas.
Bonadonna G; Valagussa P; Buzzoni R; Bajetta E
Prog Clin Biol Res; 1985; 201():369-74. PubMed ID: 2419921
[No Abstract] [Full Text] [Related]
36. Non-Hodgkin's lymphoma in children.
Brecher ML; Sinks LF; Thomas RR; Freeman AI
Cancer; 1978 May; 41(5):1997-2001. PubMed ID: 348300
[TBL] [Abstract][Full Text] [Related]
37. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of non-Hodgkin lymphoma: the diffuse types.
Sweet DL; Ultmann JE
Antibiot Chemother (1971); 1978; 24():125-33. PubMed ID: 350133
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
Case DC
J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
[No Abstract] [Full Text] [Related]
40. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
